INE03QK01018
INE03QK01018
COHANCE LIFESCIENCES LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 168.73B EUR | 174.64B EUR | 115.32B EUR | 202.19B EUR |
Enterprise Value | 170.81B EUR | 174.64B EUR | 118.84B EUR | 202.19B EUR |
Valuation Multiples | ||||
Trailing P/E | 161.54x | 164.4x | 64.34x | 126.62x |
Forward P/E | 44.96x | -- | -- | -- |
Price to Sales | 7.88x | 8.16x | 5.08x | 12.26x |
Price to Book | 4.32x | -- | 2.95x | -- |
EV/Revenue | 7.98x | 8.16x | 5.24x | 12.26x |
EV/EBITDA | 53.91x | 50.14x | 25.77x | 55.51x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |